Skip to content
Open access

NARVGA: A Hybrid Framework Integrating Matrix Factorisation and Adversarial Graph Learning for circRNA-Disease Association Prediction

Aug 2026 · Biology · Vol 15, pp. 1427 · 0 citations · 29 references
Medicine

TL;DR

A computer-based method that combines several types of biological information to predict likely relationships between circular ribonucleic acids and diseases is developed and shows a strong ability to distinguish known associations from unconfirmed ones.

Abstract

Simple Summary Circular ribonucleic acid molecules help regulate gene activity and may contribute to many diseases. However, laboratory experiments can examine only a small fraction of the possible links between these molecules and diseases, making it difficult to identify the most promising candidates for further study. This study developed a computer-based method that combines several types of biological information to predict likely relationships between circular ribonucleic acids and diseases. When tested on a widely used collection of known associations, the method showed a strong ability to distinguish known associations from unconfirmed ones. It also performed well on two related collections involving other types of ribonucleic acid. In a liver cancer case study, 19 of the 20 highest-ranked circular ribonucleic acids were supported by published studies, while one remained a potentially new candidate. These findings suggest that the method can help researchers select promising associations for laboratory testing, reduce unnecessary experimental screening, and support the discovery of disease-related markers and treatment targets.

Read PDF

Similar papers

Open access Sep 2026

NAF-CDA: A node-adaptive fusion model for circRNA-disease association prediction.

NAF-CDA is proposed, a node-adaptive robust fusion framework for circRNA-disease association prediction that constructs multi-source similarity networks from association profiles, circRNA functional information, and disease semantic information, followed by an adaptive fusion strategy to integrate complementary biologi...

Yun Zhou, Chun-Yun Song, Wen-Bo Cai et al. · 0 citations
Aug 2026

Predicting circRNA-Drug Sensitivity Using Integrated Hybrid Graph and Molecular Features.

Case studies further validated predicted circRNA-drug associations, including cisplatin, enzalutamide, and sorafenib, against published experimental findings, demonstrating HMCDSP's capacity to reveal clinically relevant biomarkers and inform personalized therapeutic strategies.

Yong-Tian Wang, Wen-Kai Shen, Jiahao Li et al. · 0 citations
Open access Sep 2026

A Graph Convolutional Network Framework Integrating Nuclear Norm Minimization and Conditional Random Fields for Microbe–Disease Association Prediction

A novel predictive model, NNGCFCAE is proposed, which integrates Nuclear Norm Minimization (NNM), an enhanced Graph Convolutional Network (GCF) with an energy-based Conditional Random Field (CRF) smoothing mechanism, and a multi-channel convolutional autoencoder (CAE) with residual connections to effectively infer late...

Zhen Zhang, Xiang-Jun Hu, Jia-Cheng Lai et al. · 0 citations
Open access Sep 2026

PMPIHGLL: predicting metabolite–protein interactions using dual hypergraph convolutional networks and large language models

A new deep-learning model for predicting MPIs, which outperformed several existing MPI prediction models and related models adapted to this task and captured higher-order relationships at different scales and expanding the feature-learning space.

Lei Chen, Zhi-Tong Jin, Ying Shao et al. · 0 citations
Aug 2026

BAMPDA: a Matrix Refactoring Framework with Heterogeneous Inference for Potential PTM-disease Association Identification.

BAMPDA is developed, a matrix refactoring framework with heterogeneous inference designed to enhance the inference of PTM-disease associations and rigorous 5-fold cross-validation demonstrates that BAM PDA significantly outperforms five recent baseline methods.

Xin-Ting Zhang, Jie Ni, Zihao Song et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.